| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Department of Biochemistry, Molecular Biology, and Cell Biology, Northwestern University (J.C.G., D.I.H.L.), Evanston, Illinois 60208; and the Department of Signal Transduction, Parke-Davis Pharmaceutical Research Division, Warner-Lambert Co. (L.-J.S., A.R.S.), Ann Arbor, Michigan 48105
Address all correspondence and requests for reprints to: Dr. Daniel I. H. Linzer, Department of Biochemistry, Molecular Biology, and Cell Biology, Northwestern University, 2153 Sheridan Road, Evanston, Illinois 60208. E-mail: dlinzer{at}nwu.edu
To investigate the mechanism of action of the placental angiogenic hormone proliferin (PLF), we analyzed the signaling components in endothelial cells that are required for PLF-induced chemotaxis. Pertussis toxin, which inactivates Gi proteins, inhibited PLF-induced chemotaxis of endothelial cells. Gi proteins can lead to activation of the mitogen-activated protein kinase (MAPK) pathway; PLF was found to stimulate MAPK activity, and this induction was blocked by both pertussis toxin and a specific inhibitor of MAPK kinase, PD 098059. Furthermore, a blockade of MAPK activation prevented endothelial cell movement in response to PLF. As PLF functionally interacts with the insulin-like growth factor II (IGF-II)/mannose 6-phosphate receptor, we also examined the effects of pertussis toxin and PD 098059 on another ligand for this receptor, a mutant form of IGF-II; both inhibitors also block the action of this factor on endothelial cells. These data suggest that chemotaxis initiated by PLF and mediated by the IGF-II/mannose 6-phosphate receptor occurs through a G protein-coupled pathway, and that MAPK activation is necessary for the chemotactic response.
This article has been cited by other articles:
![]() |
X.-Y. Wang, Y. Yin, H. Yuan, T. Sakamaki, H. Okano, and R. I. Glazer Musashi1 Modulates Mammary Progenitor Cell Expansion through Proliferin-Mediated Activation of the Wnt and Notch Pathways Mol. Cell. Biol., June 1, 2008; 28(11): 3589 - 3599. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-K. Shields, C. Nicola, and C. Chakraborty Rho Guanosine 5'-Triphosphatases Differentially Regulate Insulin-Like Growth Factor I (IGF-I) Receptor-Dependent and -Independent Actions of IGF-II on Human Trophoblast Migration Endocrinology, October 1, 2007; 148(10): 4906 - 4917. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. El-Shewy, M.-H. Lee, L. M. Obeid, A. A. Jaffa, and L. M. Luttrell The Insulin-like Growth Factor Type 1 and Insulin-like Growth Factor Type 2/Mannose-6-phosphate Receptors Independently Regulate ERK1/2 Activity in HEK293 Cells J. Biol. Chem., September 7, 2007; 282(36): 26150 - 26157. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. El-Shewy, K. R. Johnson, M.-H. Lee, A. A. Jaffa, L. M. Obeid, and L. M. Luttrell Insulin-like Growth Factors Mediate Heterotrimeric G Protein-dependent ERK1/2 Activation by Transactivating Sphingosine 1-Phosphate Receptors J. Biol. Chem., October 20, 2006; 281(42): 31399 - 31407. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.H. J. Danser and J. Deinum Renin, Prorenin and the Putative (Pro)renin Receptor Hypertension, November 1, 2005; 46(5): 1069 - 1076. [Full Text] [PDF] |
||||
![]() |
J. L. Kreiling, J. C. Byrd, and R. G. MacDonald Domain Interactions of the Mannose 6-Phosphate/Insulin-like Growth Factor II Receptor J. Biol. Chem., June 3, 2005; 280(22): 21067 - 21077. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. E. Massa, X. Li, A. Hanidu, J. Siamas, M. Pariali, J. Pareja, A. G. Savitt, K. M. Catron, J. Li, and K. B. Marcu Gene Expression Profiling in Conjunction with Physiological Rescues of IKK{alpha}-null Cells with Wild Type or Mutant IKK{alpha} Reveals Distinct Classes of IKK{alpha}/NF-{kappa}B-dependent Genes J. Biol. Chem., April 8, 2005; 280(14): 14057 - 14069. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zygmunt, T. McKinnon, F. Herr, P.K. Lala, and V.K. M. Han HCG increases trophoblast migration in vitro via the insulin-like growth factor-II/mannose-6 phosphate receptor Mol. Hum. Reprod., April 1, 2005; 11(4): 261 - 267. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Li, P. E. Massa, A. Hanidu, G. W. Peet, P. Aro, A. Savitt, S. Mische, J. Li, and K. B. Marcu IKKalpha , IKKbeta , and NEMO/IKKgamma Are Each Required for the NF-kappa B-mediated Inflammatory Response Program J. Biol. Chem., November 15, 2002; 277(47): 45129 - 45140. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-M. Kim, Y.-M. Kim, Y. M. Lee, H.-S. Kim, J. D. Kim, Y. Choi, K.-W. Kim, S.-Y. Lee, and Y.-G. Kwon TNF-related Activation-induced Cytokine (TRANCE) Induces Angiogenesis through the Activation of Src and Phospholipase C (PLC) in Human Endothelial Cells J. Biol. Chem., February 22, 2002; 277(9): 6799 - 6805. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Saris, M. M.E.D. van den Eijnden, J. M.J. Lamers, P. R. Saxena, M. A.D.H. Schalekamp, and A.H. J. Danser Prorenin-Induced Myocyte Proliferation: No Role for Intracellular Angiotensin II Hypertension, February 1, 2002; 39(2): 573 - 577. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. McKinnon, C. Chakraborty, L. M. Gleeson, P. Chidiac, and P. K. Lala Stimulation of Human Extravillous Trophoblast Migration by IGF-II Is Mediated by IGF Type 2 Receptor Involving Inhibitory G Protein(s) and Phosphorylation of MAPK J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3665 - 3674. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. W. Bengtson and D. I. H. Linzer Inhibition of Tumor Growth by the Antiangiogenic Placental Hormone, Proliferin-Related Protein Mol. Endocrinol., December 1, 2000; 14(12): 1934 - 1943. [Abstract] [Full Text] |
||||
![]() |
J. K. Tsuruta, E.M. Eddy, and D. A. O'Brien Insulin-Like Growth Factor-II/Cation-Independent Mannose 6-Phosphate Receptor Mediates Paracrine Interactions During Spermatogonial Development Biol Reprod, October 1, 2000; 63(4): 1006 - 1013. [Abstract] [Full Text] |
||||
![]() |
F. Blanchard, L. Duplomb, S. Raher, P. Vusio, B. Hoflack, Y. Jacques, and A. Godard Mannose 6-Phosphate/Insulin-like Growth Factor II Receptor Mediates Internalization and Degradation of Leukemia Inhibitory Factor but Not Signal Transduction J. Biol. Chem., August 27, 1999; 274(35): 24685 - 24693. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Blanchard, S. Raher, L. Duplomb, P. Vusio, V. Pitard, J.-L. Taupin, J.-F. Moreau, B. Hoflack, S. Minvielle, Y. Jacques, et al. The Mannose 6-Phosphate/Insulin-like Growth Factor II Receptor Is a Nanomolar Affinity Receptor for Glycosylated Human Leukemia Inhibitory Factor J. Biol. Chem., August 14, 1998; 273(33): 20886 - 20893. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Karihaloo, D. A. O'Rourke, C. Nickel, K. Spokes, and L. G. Cantley Differential MAPK Pathways Utilized for HGF- and EGF-dependent Renal Epithelial Morphogenesis J. Biol. Chem., March 16, 2001; 276(12): 9166 - 9173. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |